Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1437)	3/3/1999 2:14:00 AM
From: JGoren	Read Replies (1) \| Respond to of 2539

Anyone familiar with DuPont and how a merger would look to MTC shareholders? I personally have a bit of a problem with selling at this point. Seems like Celebrex revenues and profits should help make a major dent in the debt and give time for the genetically altered seed business to develop, and the company would be worth a lot more down the road.

To: Anthony Wong who wrote (1437)	3/3/1999 8:41:00 AM
From: jopawa	Read Replies (1) \| Respond to of 2539

Wednesday March 3, 8:17 am Eastern Time Monsanto Up at 49-3/4 Pre-open From 44-6/16 Tuesday Close (This is a headline-only alert, although it will likely be followed by an article soon)

To: Anthony Wong who wrote (1437)	3/3/1999 8:42:00 AM
From: jopawa	Respond to of 2539

From thestreet.com this morning Monsanto (MTC:NYSE) is in merger negotiations with DuPont (DD:NYSE), the New York Times reported, citing execs who say they've been briefed on the talks. Robert Shapiro, Monsanto's chief executive, has been searching for a way for Monsanto to be acquired by DuPont and still retain its special character and habits with its own compensation and incentive programs and possibly its own stock, the Times reported, citing the executives. The execs said the talks are still at a preliminary stage and may go no further, the Times said.